Pretreatment serum albumin as a predictor of cancer survival: A systematic review of the epidemiological literature
Open accessThe DOI matches its Crossref record; 100 of the 100 references it cites were found in a registry or an index.
Abstract
BACKGROUND: There are several methods of assessing nutritional status in cancer of which serum albumin is one of the most commonly used. In recent years, the role of malnutrition as a predictor of survival in cancer has received considerable attention. As a result, it is reasonable to investigate whether serum albumin has utility as a prognostic indicator of cancer survival in cancer. This review summarizes all available epidemiological literature on the association between pretreatment serum albumin levels and survival in different types of cancer. METHODS: A systematic search of the literature using the MEDLINE database (January 1995 through June 2010) to identify epidemiologic studies on the relationship between serum albumin and cancer survival. To be included in the review, a study must have: been published in English, reported on data collected in humans with any type of cancer, had serum albumin as one of the or only predicting factor, had survival as one of the outcome measures (primary or secondary) and had any of the following study designs (case-control, cohort, cross-sectional, case-series prospective, retrospective, nested case-control, ecologic, clinical trial, meta-analysis). RESULTS: Of the 29 studies reviewed on cancers of the gastrointestinal tract, all except three found higher serum albumin levels to be associated with better survival in multivariate analysis. Of the 10 studies reviewed on lung cancer, all excepting one found higher serum albumin levels to be associated with better survival. In 6 studies reviewed on female cancers and multiple cancers each, lower levels of serum albumin were associated with poor survival. Finally, in all 8 studies reviewed on patients with other cancer sites, lower levels of serum albumin were associated with poor survival. CONCLUSIONS: Pretreatment serum albumin levels provide useful prognostic significance in cancer. Accordingly, serum albumin level could be used in clinical trials to better define the baseline risk in cancer patients. A critical gap for demonstrating causality, however, is the absence of clinical trials demonstrating that raising albumin levels by means of intravenous infusion or by hyperalimentation decreases the excess risk of mortality in cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“both responses to inflammation shown to be strongly prognostic across cancer types and treatment settings 27,28 .”
From A gut microbial signature for combination immune checkpoint blockade across cancer types (2024) · cites this paper as [27]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prognostic effect of weight loss prior tochemotherapy in cancer patients
Dewys, W. D., Begg, C., Lavin, P. T., Band, P. R., Bennett, J. M., Bertino, J. R., Cohen, M. H., Douglass, H. O., Engstrom, P. F., Ezdinli, E. Z., et al. (1980) · The American Journal of Medicine · doi:10.1016/s0149-2918(05)80001-3 · Cited by 2,354 · cited 1×
“treatment, increased risk of chemotherapy-induced toxicity and a reduction in cancer survival [14].”
Background(2012) · Hepatogastroenterology · doi:10.5754/hge12458 · Cited by 1,977
Bauer, J., Capra, S., & Ferguson, M. (2002) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1601412 · Cited by 1,178 · cited 4×
“Among the most commonly used tools to measure nutritional status are subjective global assessment (SGA) [16-18], bioelectrical impedance analysis (BIA) [19], and laboratory measurements of serum albumin [20], preal-bumin, and transferrin [21,22].”
MethodInfluentialGibbs, J. (1999) · Archives of Surgery · doi:10.1001/archsurg.134.1.36 · Cited by 1,005 · cited 1×
“In the hospital setting, many reports have related serum albumin level to in-hospital mortality [35-38], length of stay (LOS) [39-41], and nosocomial infection [36,42].”
BackgroundMcMillan, D. C., Crozier, J. E. M., Canna, K., Angerson, W. J., & McArdle, C. S. (2007) · International Journal of Colorectal Disease · doi:10.1007/s00384-006-0259-6 · Cited by 533
Impact of body mass index and albumin on morbidity and mortality after cardiac surgery
Engelman, D. T., Adams, D. H., Byrne, J. G., Aranki, S. F., Collins, J. J., Couper, G. S., Allred, E. N., Cohn, L. H., & Rizzo, R. J. (1999) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(99)70056-5 · Cited by 493 · cited 1×
“In the hospital setting, many reports have related serum albumin level to in-hospital mortality [35-38], length of stay (LOS) [39-41], and nosocomial infection [36,42].”
BackgroundMcMillan, D. C., Watson, W. S., O'Gorman, P., Preston, T., Scott, H. R., & McArdle, C. S. (2001) · Nutrition and Cancer · doi:10.1207/s15327914nc392_8 · Cited by 461 · cited 2×
“icantly and serve as good indicators of prognosis of cancer [33,34].”
BackgroundRisk factors for morbidity and mortality after colectomy for colon cancer
Longo, W. E., Virgo, K. S., Johnson, F. E., Oprian, C. A., Vernava, A. M., Wade, T. P., Phelan, M. A., Henderson, W. G., Daley, J., & Khuri, S. F. (2000) · Diseases of the Colon & Rectum · doi:10.1007/bf02237249 · Cited by 416 · cited 1×
“In the hospital setting, many reports have related serum albumin level to in-hospital mortality [ 35-38 ], length of stay (LOS) [39-41], and nosocomial infection [36,42].”
BackgroundDetsky, A. S., Baker, J. P., Mendelson, R. A., Wolman, S. L., Wesson, D. E., & Jeejeebhoy, K. N. (1984) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607184008002153 · Cited by 412
Nutritional Assessment of the Hospitalized Patient
Blackburn, G. L., & Thornton, P. A. (1979) · Medical Clinics of North America · doi:10.1016/s0025-7125(16)31663-7 · Cited by 372
Hepatocellular carcinoma in the United States: Prognostic features, treatment outcome, and survival
Stuart, K. E., Anand, A. J., & Jenkins, R. L. (1996) · Cancer · doi:10.1002/(sici)1097-0142(19960601)77:11<2217::aid-cncr6>3.0.co;2-m · Cited by 354 · cited 2×
“Stuart KE, 1996, USA [68] 1986-1995 Retrospective, 314 Hepatocellular Albumin cutoffs not provided Univariate: Median survival in months Low albumin: 4 High Albumin: 15, p < 0.”
BackgroundGupta, D., Lammersfeld, C. A., Burrows, J. L., Dahlk, S. L., Vashi, P. G., Grutsch, J. F., Hoffman, S., & Lis, C. G. (2004) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/80.6.1634 · Cited by 320 · cited 3×
“Among the most commonly used tools to measure nutritional status are subjective global assessment (SGA) [16-18], bioelectrical impedance analysis (BIA) [19], and laboratory measurements of serum albumin [20], preal-bumin, and transferrin [21,22].”
MethodSelf-citationCHIMA, C. S., BARCO, K., DEWITT, M. L. A., MAEDA, M., TERAN, J. C., & MULLEN, K. D. (1997) · Journal of the American Dietetic Association · doi:10.1016/s0002-8223(97)00235-6 · Cited by 315 · cited 1×
“In the hospital setting, many reports have related serum albumin level to in-hospital mortality [35-38], length of stay (LOS) [39-41], and nosocomial infection [36,42].”
BackgroundClinical Survival Predictors in Patients With Advanced Cancer
Viganó, A., Bruera, E., Jhangri, G. S., Newman, S. C., Fields, A. L., & Suarez-Almazor, M. E. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.6.861 · Cited by 297 · cited 1×
“…loss of greater than 8.1 kg in the previous 6 months, serum albumin levels of less than 3.5 g/dL, lymphocyte counts of less than 1 × 10 9 /L, serum LDH levels of greater than 618 U/L, and clinical estimation of survival by the treating physician of less than 2 months (vs 2-6 and >6 months) [85].”
MethodInfluentialPredicting survival in patients with advanced disease
Glare, P., Sinclair, C., Downing, M., Stone, P., Maltoni, M., & Vigano, A. (2008) · European Journal of Cancer · doi:10.1016/j.ejca.2008.02.030 · Cited by 277 · cited 1×
“the key factors determining cancer survival are age, stage [2,3], number of metastatic sites involved [4], location of metastases, tachycardia, blood counts [5,6],”
BackgroundProposal of a new prognostic model for hepatocellular carcinoma: an analysis of 403 patients
Tateishi, R., Yoshida, H., Shiina, S., Imamura, H., Hasegawa, K., Teratani, T., Obi, S., Sato, S., Koike, Y., Fujishima, T., et al. (2005) · Gut · doi:10.1136/gut.2003.035055 · Cited by 273 · cited 2×
“in 403 patients with HCC found serum albumin, bilirubin, size of the tumor, and number of tumor nodules to be independent predictors of survival [61].”
BackgroundIshizuka, M., Nagata, H., Takagi, K., Horie, T., & Kubota, K. (2007) · Annals of Surgery · doi:10.1097/sla.0b013e3181454171 · Cited by 272 · cited 3×
“Ishizuka M, 2007, Japan [3] January 2001 to March 2006 Retrospective, 315 Colorectal <=3.”
BackgroundSerum Albumin as a Significant Prognostic Factor for Patients with Gastric Carcinoma
Oñate-Ocaña, L. F., Aiello-Crocifoglio, V., Gallardo-Rincón, D., Herrera-Goepfert, R., Brom-Valladares, R., Carrillo, J. F., Cervera, E., & Mohar-Betancourt, A. (2007) · Annals of Surgical Oncology · doi:10.1245/s10434-006-9093-x · Cited by 264 · cited 3×
“Onate-Ocana LF, 2007, Mexico [44] January 1987 to December 2002 Retrospective, 1023 Gastric High: >=3.”
BackgroundFactors influencing serum albumin in dialysis patients
Yeun, J., & Kaysen, G. (1998) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(98)70174-x · Cited by 239 · cited 1×
“Malnutrition and inflammation suppress albumin synthesis [29].”
Prognostic factors for patients with hepatic metastases from breast cancer
Wyld, L., Gutteridge, E., Pinder, S. E., James, J. J., Chan, S. Y., Cheung, K. L., Robertson, J. F. R., & Evans, A. J. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601038 · Cited by 207 · cited 2×
“Wyld L 2003, UK [80] January 1997 to January 2002 Retrospective, 145 Breast cancer with liver metastases First group <3.”
BackgroundCheng, P. N.-M., & Saltz, L. B. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19990915)86:6<1044::aid-cncr21>3.0.co;2-c · Cited by 200
Cancer-associated malnutrition: An introduction
von Meyenfeldt, M. (2005) · European Journal of Oncology Nursing · doi:10.1016/j.ejon.2005.09.001 · Cited by 198 · cited 1×
“anticancer therapies [13].”
A prognostic model for ovarian cancer
Clark, T. G., Stewart, M., Altman, D. G., Gabra, H., & Smyth, J. F. (2001) · British Journal of Cancer · doi:10.1038/sj.bjc.6692030 · Cited by 192 · cited 2×
“05) prognostic factors for overall survival were age at diagnosis, FIGO stage, grade of tumor, histology (mixed mesodermal, clear cell and endometrioid versus serous papillary), the presence or absence of ascites, albumin, ALP, PS, and debulking of the tumor [81].”
BackgroundLaky, B., Janda, M., Cleghorn, G., & Obermair, A. (2008) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/87.6.1678 · Cited by 191 · cited 5×
“Using univariate analysis, significantly worse survival was found for patients with poorer performance status, high GPS, low albumin, elevated serum alkaline phosphatase (ALP), patient-generated subjective global assessment (PGSGA) score of >9.”
BackgroundMethodInfluentialDying with cancer, living well with advanced cancer
Higginson, I. J., & Costantini, M. (2008) · European Journal of Cancer · doi:10.1016/j.ejca.2008.02.024 · Cited by 184 · cited 1×
“ence cancer and 10 million will die from it each year [1].”
BackgroundDi Fiore, F., Lecleire, S., Pop, D., Rigal, O., Hamidou, H., Paillot, B., Ducrotté, P., Lerebours, E., & Michel, P. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01437.x · Cited by 182 · cited 4×
“A study assessing the impact of baseline nutritional status on treatment response and survival in nonmetastatic patients with a locally advanced esophageal cancer treated with definitive chemoradiotherapy (CRT) found that in multivariate analysis, serum albumin level >3.5 g/dL was the only independent predictive facto…”
BackgroundInfluentialRead, J. A., Boris Choy, S. T., Beale, P. J., & Clarke, S. J. (2006) · Nutrition and Cancer · doi:10.1207/s15327914nc5501_10 · Cited by 182 · cited 2×
“Upon multivariate analysis, type of treatment, PS, GPS, and ALP remained significant predictors of survival [56].”
BackgroundMethodSacks, G. S., Dearman, K., Replogle, W. H., Cora, V. L., Meeks, M., & Canada, T. W. (2000) · Journal of the American College of Nutrition · doi:10.1080/07315724.2000.10718954 · Cited by 178 · cited 1×
“In the hospital setting, many reports have related serum albumin level to in-hospital mortality [35-38], length of stay (LOS) [39-41], and nosocomial infection [36,42].”
BackgroundPreoperative serum albumin level is a prognostic indicator for adenocarcinoma of the gastric cardia
Lien, Y.-C., Hsieh, C.-C., Wu, Y.-C., Hsu, H.-S., Hsu, W.-H., Wang, L.-S., Huang, M.-H., & Huang, B.-S. (2004) · Journal of Gastrointestinal Surgery · doi:10.1016/j.gassur.2004.09.033 · Cited by 175 · cited 2×
“albumin level and the pathologic T, N statuses were independent factors correlated with prognosis [63].”
BackgroundChanges in Nutritional, Functional, and Inflammatory Markers in Advanced Pancreatic Cancer
Barber, M. D., Ross, J. A., & Fearon, K. C. H. (1999) · Nutrition and Cancer · doi:10.1207/s15327914nc352_2 · Cited by 172 · cited 3×
“icantly and serve as good indicators of prognosis of cancer [33,34].”
BackgroundForrest, L. M., McMillan, D. C., McArdle, C. S., Angerson, W. J., Dagg, K., & Scott, H. R. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602591 · Cited by 159 · cited 1×
“In contrast, neither the GPS nor PS measured at 3-6 months follow-up were significant predictors of residual survival [71].”
BackgroundIs serum albumin an independent predictor of survival in patients with breast cancer?
Lis, C. G., Grutsch, J. F., Vashi, P. G., & Lammersfeld, C. A. (2003) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/014860710302700110 · Cited by 156 · cited 2×
“Lis CG, 2003, USA [46] March 1993 to December 1999 Retrospective consecutive case series, 180 Breast >=3.”
BackgroundSelf-citationSimons, J., Schols, A. M. W. J., Buurman, W. A., & Wouters, E. F. �. (1999) · Clinical Science · doi:10.1042/cs0970215 · Cited by 156
O'Gorman, P., McMillan, D. C., & McArdle, C. S. (1998) · Nutrition and Cancer · doi:10.1080/01635589809514722 · Cited by 143
Boonpipattanapong, T., & Chewatanakornkul, S. (2006) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-200608000-00006 · Cited by 140 · cited 3×
“tumor markers [7,8], performance status (PS) [9,10], quality of life and malnutrition [11,12].”
BackgroundNutritional screening and assessment in cancer-associated malnutrition
Davies, M. (2005) · European Journal of Oncology Nursing · doi:10.1016/j.ejon.2005.09.005 · Cited by 138 · cited 1×
“Others include anthropometric parameters [21,23,24] such as weight loss, arm muscle circumference, skin-fold thickness [18,25], and presence of edema and ascites [26].”
BackgroundPrognostic Scoring in Colorectal Cancer Liver Metastases
Schindl, M. (2005) · Archives of Surgery · doi:10.1001/archsurg.140.2.183 · Cited by 129 · cited 2×
“Schindl M, 2005, UK [60] October 1, 1988, to January 31, 2002 Retrospective, 337 Colorectal Continuous variable Univariate: p < 0.”
BackgroundSerum albumin: a prognostic indicator in patients with colorectal cancer.
Heys, S. D., Walker, L. G., Deehan, D. J., & Eremin, O. (1998) · PubMed · Cited by 126
Predictors of Outcome in Cardiac Surgical Patients With Prolonged Intensive Care Stay
Ryan, T. A., Rady, M. Y., Bashour, C. A., Leventhal, M., Lytle, B. W., & Starr, N. J. (1997) · CHEST Journal · doi:10.1378/chest.112.4.1035 · Cited by 121 · cited 1×
“In the hospital setting, many reports have related serum albumin level to in-hospital mortality [35-38], length of stay (LOS) [39-41], and nosocomial infection [36,42].”
BackgroundEspinosa, E., Feliú, J., Zamora, P., Barón, M. G., Sánchez, J. J., Ordónez, A., & Espinosa, J. (1995) · Lung Cancer · doi:10.1016/0169-5002(95)00407-r · Cited by 118 · cited 2×
“Espinosa E, 1995, Spain [76] 1980-1992 Retrospective onsecutive case series, 292 Non Small Cell Lung >=4 g/dL <4 g/dL Univariate: Median survival in months For >=4 g/dL = 9 For <4 g/dL = 7, p = 0.”
BackgroundPrognostic significance of Subjective Global Assessment (SGA) in advanced colorectal cancer
Gupta, D., Lammersfeld, C. A., Vashi, P. G., Burrows, J., Lis, C. G., & Grutsch, J. F. (2004) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1602029 · Cited by 118 · cited 4×
“Among the most commonly used tools to measure nutritional status are subjective global assessment (SGA) [16-18], bioelectrical impedance analysis (BIA) [19], and laboratory measurements of serum albumin [20], preal-bumin, and transferrin [21,22].”
MethodInfluentialSelf-citationBiological indices predictive of survival in 519 Italian terminally Ill cancer patients
Maltoni, M. C., Pirovano, M., Nanni, O., Marinari, M., Indelli, M., Gramazio, A., Terzoli, E., Luzzani, M., de Marinis, F., Caraceni, A. T., et al. (1997) · Journal of Pain and Symptom Management · doi:10.1016/s0885-3924(96)00265-5 · Cited by 117 · cited 2×
“cholinesterase levels, and high proteinuria [86].”
BackgroundIshizuka, M., Nagata, H., Takagi, K., & Kubota, K. (2009) · Annals of Surgery · doi:10.1097/sla.0b013e3181b16e24 · Cited by 115 · cited 1×
“Ishizuka M, 2009, Japan [48] April 2005 to July 2007 Retrospective, 112 Colorectal <3.”
BackgroundDixon, M. R. (2003) · Archives of Surgery · doi:10.1001/archsurg.138.9.962 · Cited by 114 · cited 3×
“7 g/dL and a CEA level less than 275 ng/mL had a longer survival time [67].”
BackgroundSève, P., Ray-Coquard, I. L., Trillet-Lenoir, V. N., Sawyer, M. B., Hanson, J., Broussolle, C., Négrier, S., Dumontet, C., & Mackey, J. R. (2006) · Cancer · doi:10.1002/cncr.22300 · Cited by 114
Elahi, M. M., McMillan, D. C., McArdle, C. S., Angerson, W. J., & Sattar, N. A. (2004) · Nutrition and Cancer · doi:10.1207/s15327914nc4802_6 · Cited by 113 · cited 2×
“advanced gastrointestinal cancer and found that a cumulative score based on these two parameters was a useful prognostic indicator [64].”
BackgroundRole of hypoalbuminemia and hypocholesterolemia as copredictors of mortality in acute renal failure
Obialo, C. I., Okonofua, E. C., Nzerue, M. C., Tayade, A. S., & Riley, L. J. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00622.x · Cited by 111 · cited 1×
“In the hospital setting, many reports have related serum albumin level to in-hospital mortality [35-38], length of stay (LOS) [39-41], and nosocomial infection [36,42].”
BackgroundSun, L., Chu, K., Cheng, S.-C., Lu, C.-Y., Kuo, C., Hsieh, J., Shih, Y., Chang, S., & Wang, J. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-288 · Cited by 111 · cited 2×
“Sun LC, 2009, Taiwan [50] January 1996 to December 2006 Retrospective cohort, 1367 Colorectal <3.”
BackgroundCengiz, Ö., Kocer, B., Sürmeli, S., Santicky, M.-J., & Soran, A. (2006) · PubMed · Cited by 106
Ballmer, P. E., Ochsenbein, A. F., & Schütz-Hofmann, S. (1994) · Metabolism · doi:10.1016/0026-0495(94)90117-1 · Cited by 102 · cited 1×
“later stages of disease, malnutrition and inflammation suppress albumin synthesis [30].”
BackgroundBaseline Nutritional Assessment in Advanced Cancer Patients Receiving Palliative Chemotherapy
Slaviero, K. A., Read, J. A., Clarke, S. J., & Rivory, L. P. (2003) · Nutrition and Cancer · doi:10.1207/s15327914nc4602_07 · Cited by 100 · cited 1×
“Others include anthropometric parameters [21,23,24] such as weight loss, arm muscle circumference, skin-fold thickness [18,25], and presence of edema and ascites [26].”
BackgroundSerum C‐reactive protein levels predict survival in hepatocellular carcinoma
Nagaoka, S., Yoshida, T., Akiyoshi, J., Akiba, J., Torimura, T., Adachi, H., Kurogi, J., Tajiri, N., Inoue, K., Niizeki, T., et al. (2007) · Liver International · doi:10.1111/j.1478-3231.2007.01550.x · Cited by 100 · cited 2×
“A study investigating the relationship between the serum levels of high sensitivity CRP (H-CRP) and the prognosis of HCC patients found positive H-CRP, albumin, tumor stage and initial treatment to be significant independent determinants of poor prognosis [ 55 ].”
BackgroundInfluentialNutritional factors and survival of patients with oral cancer
Liu, S., Tsai, W., Wong, Y., Lin, J., Poon, C., Chao, S., Hsiao, Y., Chan, M., Cheng, C., Wang, C., et al. (2006) · Head & Neck · doi:10.1002/hed.20461 · Cited by 98 · cited 2×
“Liu SA, 2006, Taiwan [57] March 1995 to December 2002 Retrospective, 1010 Oral >=4.”
BackgroundWang, C., Hsieh, M.-J., Chiu, Y., Li, S.-H., Huang, H., Fang, F., & Huang, Y.-J. (2009) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2009.01.002 · Cited by 95 · cited 2×
“Wang CY, 2009, Taiwan [51] November 2002 to July 2007 Prospective, 123 Esophageal >=3.”
BackgroundPredictors of early mortality in veteran patients with pancreatic cancer
Siddiqui, A. A., Heinzerling, J. H., Livingston, E. H., & Huerta, S. (2007) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2007.02.007 · Cited by 90 · cited 3×
“Siddiqui A, 2007, USA [6] July 1986 to December 2004 Retrospective, 69 Pancreas >=3.”
BackgroundPrognosis in lung cancer: physicians' opinions compared with outcome and a predictive model.
Muers, M. F., Shevlin, P. M., & Brown, J. (1996) · Thorax · doi:10.1136/thx.51.9.894 · Cited by 89 · cited 2×
“Muers MF, 1996, UK [74] NA Retrospective consecutive case series, 207 Non Small Cell Lung NA Prognostic Index = -0.”
BackgroundXu, H., Lu, M., Xie, X.-Y., Yin, X.-Y., Kuang, M., Chen, J.-W., Xu, Z.-F., & Liu, G.-J. (2005) · Clinical Radiology · doi:10.1016/j.crad.2005.04.009 · Cited by 87 · cited 1×
“Xu HX, 2005, China [62] August 1997 to September 2003 Prospective consecutive case series, 137 Hepatocellular <3.”
BackgroundRequirements for Clinical Use of Bioelectrical Impedance Analysis (BIA)a
Lukaski, H. C. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb09451.x · Cited by 87 · cited 1×
“Similarly, though BIA is easy-to-use, noninvasive, and reproducible, it relies on regression models derived in restricted samples of human subjects, which thus limits the usefulness of the derived model in other patients who differ from the original sample [27,28].”
BackgroundSurvival predictors in advanced non-small cell lung cancer
Hespanhol, V. P., Queiroga, H., Magalhães, A., Santos, A. R., Coelho, M., & Marqués, J. (1995) · Lung Cancer · doi:10.1016/0169-5002(95)00497-1 · Cited by 85 · cited 2×
“Hespanhol V, 1995, Portugal [75] 1984 to 1990 Prospective, 411 Non Small Cell Lung <3.”
BackgroundEvaluation of an inflammation-based prognostic score in patients with advanced ovarian cancer
Sharma, R., Hook, J., Kumar, M., & Gabra, H. (2008) · European Journal of Cancer · doi:10.1016/j.ejca.2007.11.011 · Cited by 85 · cited 2×
“On multivariate analysis, a high GPS score, non-serous histology, high ALP and no initial surgery were independent predictors of worse overall survival [ 78 ].”
BackgroundInfluentialHepatocellular carcinoma in the United States.
Tabibian, N. (1988) · PubMed · Cited by 85
Alphs, H. H., ZAHURAK, M. L., Bristow, R. E., & Diaz-Montes, T. P. (2006) · Gynecologic Oncology · doi:10.1016/j.ygyno.2006.06.019 · Cited by 84 · cited 2×
“Alphs HH, 2006, USA [79] January 1, 1990 to June 30, 2004 Retrospective, 78 Ovarian and primary peritoneal >=3.”
BackgroundMaestu, I., Pastor, M., Gómez‐Codina, J., Aparicio, J., Oltra, A., Herranz, C., Montalar, J., Munárriz, B., & Reynés, G. (1997) · Annals of Oncology · doi:10.1023/a:1008212826956 · Cited by 83 · cited 2×
“Maestu I, 1997, Spain [73] November 1981 to January 1993 Retrospective, 341 Small cell lung <3.”
BackgroundMethodChoi, G. H., Kim, D. H., Kang, C. M., Kim, K. S., Choi, J., Lee, W. J., & Kim, B.-R. (2007) · Annals of Surgical Oncology · doi:10.1245/s10434-007-9671-6 · Cited by 83 · cited 2×
“5 g/ dL at diagnosis of recurrence were poor prognostic factors for survival [52].”
BackgroundChen, M., Tsai, H.-P., Jeng, L., Lee, W., Yeh, C., Yu, M., & Hung, C. (2003) · World Journal of Surgery · doi:10.1007/s00268-002-6708-7 · Cited by 82 · cited 2×
“sion, resection margin, and multiple tumors were shown to be significant independent factors that influenced overall survival rates [65].”
BackgroundSantarpia, L., Alfonsi, L., Pasanisi, F., Caprio, C. D., Scalfi, L., & Contaldo, F. (2006) · Nutrition · doi:10.1016/j.nut.2005.06.011 · Cited by 78 · cited 1×
“Santarpia L, 2006, Italy [83] January 1996 to September 2003 Retrospective, 152 Stomach, ovaries, colorectal, endometrium, breast, ileum, gallbladder, pancreas, kidney, skin, prostate, abdominal sarcoma, unknown Mean (SD) 2.”
Assessment of nutritional status and fluid deficits in advanced cancer
Sarhill, N., Mahmoud, F. A., Christie, R., & Tahir, A. (2003) · American Journal of Hospice and Palliative Medicine® · doi:10.1177/104990910302000610 · Cited by 75 · cited 1×
“There are various methods of assessing nutritional status in cancer, each with its own advantages and disadvantages [15].”
MethodMaltoni, M. C., & Amadori, D. (2002) · Hematology/Oncology Clinics of North America · doi:10.1016/s0889-8588(02)00024-2 · Cited by 74
Pasanisi, F., Orbán, A., Scalfi, L., Alfonsi, L., Santarpia, L., Zurlo, E., Celona, A., Potenza, A., & Contaldo, F. (2001) · Nutrition (Burbank, Los Angeles County, Calif.) · doi:10.1016/s0899-9007(01)00579-2 · Cited by 71 · cited 1×
“Pasanisi F, 2001, Italy [84] 1995-1999 Retrospective consecutive case series, 76 Stomach, colorectal, ovary, others Mean (SD) 3.”
Assessment of nutritional status in cancer patients: widely neglected?
Delmore, G. (1997) · Supportive Care in Cancer · doi:10.1007/s005200050095 · Cited by 69
Citterio, G., Bertuzzi, A. F., Tresoldi, M., Galli, L., Lucca, G. D., Scaglietti, U., & Rugarli, C. (1997) · European Urology · doi:10.1159/000474469 · Cited by 68 · cited 1×
“Citterio G, 1997, Italy [93] 1988 onwards Retrospective consecutive case series, 109 Renal cell NA Univariate: p < 0.”
BackgroundNeal, C. P., Mann, C. D., Sutton, C. D., Garcea, G., Ong, S. L., Steward, W. P., Dennison, A. R., & Berry, D. P. (2008) · European Journal of Cancer · doi:10.1016/j.ejca.2008.08.019 · Cited by 63 · cited 2×
“…of pre-operative systemic inflammatory biomarkers and socioeconomic deprivation in patients undergoing resection of colorectal liver metastases found poor clinical risk score (3-5), high neutrophil count (>6.0 × 10(9)/l) and low serum albumin ( 4 g/dL) to be the only independent predictors [49].”
BackgroundInfluentialLjungberg, B., Landberg, G., & Alamdari, F. I. (2000) · Scandinavian Journal of Urology and Nephrology · doi:10.1080/003655900750041979 · Cited by 62 · cited 2×
“Ljungberg B, 2000, Sweden [90] April 1982 to February 1999 Retrospective consecutive case series, 106 Renal cell Continuous variable Univariate: NA, p = 0.”
BackgroundIdentifying prognostic factors for survival in advanced cancer patients: a prospective study.
Lam, P. T., Leung, M. W., & Tse, C. Y. (2007) · PubMed · Cited by 59
Prognostic factors among cancer patients with good performance status screened for phase I trials
Penel, N., Vanseymortier, M., Bonneterre, M.-E., Clisant, S., Dansin, É., Vendel, Y., Beuscart, R., & Bonneterre, J. M. (2007) · Investigational New Drugs · doi:10.1007/s10637-007-9088-x · Cited by 55 · cited 2×
“The Cox model identified serum albumin and lymphocyte count as independent prognostic factors [82].”
BackgroundMethodMaeda, T. (2000) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyd139 · Cited by 54 · cited 3×
“tumor markers [7,8], performance status (PS) [9,10], quality of life and malnutrition [11,12].”
BackgroundMethodTas, A. A. F. F. (1999) · Acta Oncologica · doi:10.1080/028418699432275 · Cited by 50 · cited 2×
“tumor markers [7,8], performance status (PS) [9,10], quality of life and malnutrition [11,12].”
BackgroundLong-Term Follow-Up and Prognostic Factors in Ewing’s Sarcoma
Aparicio, J., Munárriz, B., Pastor, M., Vera-Sempere, F. J., Castel, V., Aparisi, F., Montalar, J., Badal, M. D., Gómez‐Codina, J., & Herranz, C. (1997) · Oncology · doi:10.1159/000011841 · Cited by 48
Predicting Survival in Potentially Curable Lung Cancer Patients
Win, T., Sharples, L. D., Groves, A. M., Ritchie, A. J., Wells, F. C., & LAROCHE, C. M. (2008) · Lung · doi:10.1007/s00408-007-9067-1 · Cited by 48 · cited 2×
“Win T, 2008, UK [70] 2 years up to December 2006 Prospective consecutive case series, 110 Non Small Cell Lung Continuous variable Univariate: 0.”
BackgroundRay, P., Quantin, X., Grenier, J., & Pujol, J.-L. (1998) · Cancer Detection and Prevention · doi:10.1046/j.1525-1500.1998.cdoa43.x · Cited by 47 · cited 3×
“All studies excepting one [4] concluded that higher serum albumin levels were associated with better survival.”
BackgroundUnderstanding the relationship between relative and absolute risk
Dupont, W. D., & Plummer, W. D. (1996) · Cancer · doi:10.1002/(sici)1097-0142(19960601)77:11<2193::aid-cncr2>3.0.co;2-r · Cited by 45
Analysis of survival factors in patients with advanced-stage gastric adenocarcinoma.
Alıcı, S., Kaya, S., İzmirli, M., Tuncer, İ., Doğan, E., Özbek, H., & Sayarlıoğlu, H. (2006) · PubMed · Cited by 42
Simple Predictors of Survival in Head and Neck Squamous Cell Carcinoma
Medow, M. A., Weed, H. G., & Schuller, D. E. (2002) · Archives of Otolaryngology - Head and Neck Surgery · doi:10.1001/archotol.128.11.1282 · Cited by 41 · cited 2×
“Medow MA, 2002, USA [89] July 1993 to June 1997 Retrospective consecutive case series, 406 Head and neck <3.”
BackgroundNutritional predictors of survival in terminally ill cancer patients.
Ho, S., Guo, H., Chen, H. H. W., & Peng, C.-J. (2003) · PubMed · Cited by 40
Analysis of risk factors for nosocomial sepsis in surgical patients
Fariñas-Álvarez, C., Fariñas, M. C., Fernández-Mazarrasa, C., Llorca, J., Casanova, D., & Delgado‐Rodríguez, M. (2000) · British journal of surgery · doi:10.1046/j.1365-2168.2000.01466.x · Cited by 38 · cited 1×
“In the hospital setting, many reports have related serum albumin level to in-hospital mortality [35-38], length of stay (LOS) [39-41], and nosocomial infection [36,42].”
BackgroundPresurgical Serum Albumin Levels Predict Survival Time from Glioblastoma Multiforme
Schwartzbaum, J., Lal, P., Evanoff, W. A., Mamrak, S. A., Yates, A. J., Barnett, G. H., Goodman, J. H., & Fisher, J. L. (1999) · Journal of Neuro-Oncology · doi:10.1023/a:1006269413998 · Cited by 34 · cited 2×
“Schwartzbaum JA, 1999, USA [91] February 1, 1993 to December 31, 1995 A convenience sample, 24 Glioblastoma multiforme 1 Quartile (2.”
BackgroundDuguet, A., Bachmann, P., Lallemand, Y., & Blanc-Vincent, M. P. (1999) · PubMed · Cited by 32
Different profiles of allelic losses in cervical carcinoma cases in Surinam and the Netherlands
Krul, E. J. T., van der Kevie-Kersemaekers, A.-M. F., Zomerdijk‐Nooyen, Y. A., Cornelisse, C. J., Peters, L. A. W., & Fleuren, G. J. (1999) · Cancer · Cited by 31
Impact of nutritional status on the survival of lung cancer patients.
Sl, L., & Rp, P. (1998) · PubMed · Cited by 28
Takahashi, S., Kudo, M., Chung, H., Inoue, T., Ishikawa, E., Kitai, S., Tatsumi, C., 上田, 泰., Nagai, T., Minami, Y., et al. (2008) · Oncology · doi:10.1159/000173429 · Cited by 25 · cited 2×
“(PIVKA-II), and multiple nodules to be independently prognostic of survival [53].”
BackgroundEvaluation of Nutritional Status
Curtas, S., Chapman, G., & Meguid, M. M. (1989) · Nursing Clinics of North America · doi:10.1016/s0029-6465(22)01486-4 · Cited by 23
Local recurrence is an important prognostic factor of hepatocellular carcinoma
Arimura, E. (2005) · World Journal of Gastroenterology · doi:10.3748/wjg.v11.i36.5601 · Cited by 23 · cited 3×
“of HCC found the indocyanine green retention at 15 min (ICG) test, tumor size, tumor number, and local recurrence to be the significant prognostic factors of survival upon multivariate analysis [59].”
BackgroundSerum albumin is an independent prognostic factor for survival in soft tissue sarcomas.
Barreto-Andrade, J. C., & Medina‐Franco, H. (2009) · PubMed · Cited by 19
Nutritional assessment of the hospitalized patient.
En, M., & Ll, L. (1983) · PubMed · Cited by 19
[Prognostic factors in 793 cases of gastric cancer in an oncologic referral center].
Oñate-Ocaña, L. F., Crocifoglio, V. A., Mondragón–Sánchez, R., Molina, J. M. R., & Gallardo‐Rincón, D. (1999) · PubMed · Cited by 18
Prognostic Factors in Localized Aggressive Non-Hodgkin’s Lymphoma
Alıcı, S., Bavbek, S. E., Kaytan, E., Eralp, Y., & Onat, H. (2003) · American Journal of Clinical Oncology · doi:10.1097/00000421-200302000-00001 · Cited by 18 · cited 1×
“Alici S, 2003, Turkey [88] 1989 to 1998 Retrospective, 110 NonHodgkin’s Lymphoma Normal Low Univariate: p = 0.”
Koike, Y., Nakagawa, K., Shiratori, Y., Shiina, S., Imamura, M., Sato, S., Obi, S., Teratani, T., Hamamura, K., Yoshida, H., et al. (2003) · PubMed · Cited by 18
Elia, M. (1993) · PubMed · Cited by 18
Is Serum Albumin an Independent Predictor of Survival in Ovarian Cancer?
Gupta, D., Lammersfeld, C. A., Vashi, P. G., Dahlk, S., Grutsch, J. F., & Lis, C. G. (2009) · Clinical Ovarian Cancer · doi:10.3816/coc.2009.n.008 · Cited by 17
Self-citationSimple assessment of the nutritional status in the critically ill patient
Boles, J. M., Garré, M., & Youinou, P. (1984) · Resuscitation · doi:10.1016/0300-9572(84)90020-0 · Cited by 13 · cited 1×
“Among the most commonly used tools to measure nutritional status are subjective global assessment (SGA) [16-18], bioelectrical impedance analysis (BIA) [19], and laboratory measurements of serum albumin [20], prealbumin, and transferrin [21,22].”
Method
Cited by
Human serum albumin: From bench to bedside
Fanali, G., di Masi, A., Trezza, V., Marino, M., Fasano, M., & Ascenzi, P. (2012) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2011.12.002 · Cited by 1,931
Levitt, D., & Levitt, M. (2016) · International Journal of General Medicine · doi:10.2147/ijgm.s102819 · Cited by 763
Cupp, M. A., Cariolou, M., Tzoulaki, I., Aune, D., Evangelou, E., & Berlanga-Taylor, A. J. (2020) · BMC Medicine · doi:10.1186/s12916-020-01817-1 · Cited by 697
Exploiting the critical perioperative period to improve long-term cancer outcomes
Horowitz, M., Neeman, E., Sharon, E., & Ben-Eliyahu, S. (2015) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2014.224 · Cited by 487
Cespedes Feliciano, E. M., Kroenke, C. H., Meyerhardt, J. A., Prado, C. M., Bradshaw, P. T., Kwan, M. L., Xiao, J., Alexeeff, S., Corley, D., Weltzien, E., et al. (2017) · JAMA Oncology · doi:10.1001/jamaoncol.2017.2319 · Cited by 427
“5g/dL (thecutoff forhypoalbuminemia; to convert to grams per liter, multiply by 10).(14)”
Metadata
- Authors
- Gupta, D., & Lis, C. G.
- Affiliations
- Cancer Treatment Centers of America (US)
- Corresponding author
- Lis, Christopher G
- ORCID
- Gupta, Digant
- Venue
- Nutrition Journal
- Published
- 2010-12
- Volume
- 9
- Issue
- 1
- Pages
- 69-69
- ISSN
- 1475-2891 (ISSN-L)
- PMC
- PMC3019132
- OpenAlex
- W2167127503
- Cited by
- 1,485
- References
- 98
- Citations by year
- 2026: 122 · 2025: 147 · 2024: 138 · 2023: 152 · 2022: 161 · 2021: 178 · 2020: 140 · 2019: 86 · 2018: 83 · 2017: 72 · 2016: 64 · 2015: 56 · 2014: 34 · 2013: 24 · 2012: 11
- FWCI
- 1.70
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Nutrition Journal (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Oncology › Inflammatory Biomarkers in Disease Prognosis
- Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
- Health Sciences › Nursing › Nutrition and Dietetics › Clinical Nutrition and Gastroenterology
- Keywords
- serum albumin, cancer survival, prognostic factors, malnutrition, nutritional status, gastrointestinal cancer, lung cancer, women's cancer, multiple primary neoplasms, mortality risk
- MeSH terms
- Female, Humans, Male, Neoplasms, Prognosis, Serum Albumin, Nutrition Assessment, Malnutrition
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.